IMAB vs ENTA

Comparison between I-Mab (IMAB, Company) and Enanta Pharmaceuticals Inc (ENTA, Company).

Both IMAB and ENTA are from the Healthcare sector.

5-Year PerformanceENTA has outperformed IMAB, delivering a return of -24.1% compared to -35.3%

IMAB vs ENTA - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	IMAB(COMPANY)	ENTA(COMPANY)
Market Cap	$340M	$340M
Max Drawdown	99.27%	96.63%
Sharpe Ratio	1.64	0.75
5Y Beta	0.87	1.04
Industry	Biotechnology	Biotechnology
P/E Ratio	-8.89	-2.11
Forward P/E	N/A	44.05
PEG Ratio	N/A	-0.09
5Y EPS CAGR	N/A	8.56%
Debt to Equity	1.77%	0.00%
Free Cash Flow Yield	N/A	-2.83%
P/S Ratio	N/A	4.77
P/B Ratio	1.73	2.83

Market Cap

IMAB

$340M

Winner

ENTA

$340M

Max Drawdown

IMAB

99.27%

Winner

ENTA

96.63%

Sharpe Ratio

Winner

IMAB

1.64

ENTA

0.75

5Y Beta

Winner

IMAB

0.87

ENTA

1.04

Industry

IMAB

Biotechnology

ENTA

Biotechnology

P/E Ratio

Winner

IMAB

-8.89

ENTA

-2.11

Forward P/E

IMAB

N/A

ENTA

44.05

PEG Ratio

IMAB

N/A

ENTA

-0.09

5Y EPS CAGR

IMAB

N/A

ENTA

8.56%

Debt to Equity

IMAB

1.77%

Winner

ENTA

0.00%

Free Cash Flow Yield

IMAB

N/A

ENTA

-2.83%

P/S Ratio

IMAB

N/A

ENTA

4.77

P/B Ratio

Winner

IMAB

1.73

ENTA

2.83

IMAB vs ENTA - Historical Returns

Returns include dividend reinvestment.

Period	IMAB	ENTA
1 month	+35.38%	-18.10%
3 months	+172.35%	-11.26%
6 months	+470.20%	-19.21%
1 year	+292.37%	+60.59%
5 years(CAGR)	-35.30%	-24.06%
10 years(CAGR)	N/A	-6.39%
Max(CAGR)	-15.78%	-2.74%

Winner

IMAB

+35.38%

ENTA

-18.10%

Winner

IMAB

+172.35%

ENTA

-11.26%

Winner

IMAB

+470.20%

ENTA

-19.21%

Winner

IMAB

+292.37%

ENTA

+60.59%

5Y(CAGR)

IMAB

-35.30%

Winner

ENTA

-24.06%

10Y(CAGR)

IMAB

N/A

ENTA

-6.39%

Max(CAGR)

IMAB

-15.78%

Winner

ENTA

-2.74%

IMAB vs ENTA - Annual Returns (2013 - 2026)

Returns include dividend reinvestment.

Year	IMAB	ENTA
2026	N/A	-17.48%
2025	+411.04%	+182.11%
2024	-62.22%	-42.96%
2023	-55.19%	-79.43%
2022	-91.09%	-37.23%
2021	+4.75%	+77.62%
2020	+277.20%	-32.10%
2019	N/A	-14.62%
2018	N/A	+22.18%
2017	N/A	+70.83%
2016	N/A	-2.02%
2015	N/A	-34.55%
2014	N/A	+79.81%
2013	N/A	+58.79%

IMAB vs ENTA Drawdown Comparison

The maximum drawdown for IMAB was -99.27%, occurring on Apr 7, 2025. This drawdown has not yet recovered.

The maximum drawdown for ENTA was -96.63%, occurring on Apr 10, 2025. This drawdown has not yet recovered.

The current IMAB drawdown is -94.52%. The current ENTA drawdown is -90.58%.

Rank	IMAB	ENTA
#1	-99.27% Jul 1, 2021 - Apr 7, 2025	-96.63% Jul 9, 2018 - Apr 10, 2025
#2	-30.84% Jan 22, 2020 - Apr 27, 2020	-59.60% Dec 29, 2014 - Dec 13, 2017
#3	-30.62% Mar 1, 2021 - Apr 26, 2021	-28.47% Dec 10, 2013 - Feb 4, 2014
#4	-29.96% Sep 30, 2020 - Dec 31, 2020	-24.24% Sep 20, 2013 - Nov 26, 2013
#5	-18.59% May 19, 2020 - Jun 15, 2020	-23.97% Apr 10, 2013 - Sep 18, 2013
#6	-16.81% Feb 2, 2021 - Mar 1, 2021	-22.54% Mar 20, 2014 - Jun 18, 2014
#7	-16.15% Apr 29, 2020 - May 12, 2020	-20.33% Feb 6, 2018 - Apr 26, 2018
#8	-15.22% Jul 13, 2020 - Aug 31, 2020	-19.61% Jun 19, 2014 - Oct 20, 2014
#9	-14.70% Jan 8, 2021 - Feb 1, 2021	-14.27% Nov 26, 2014 - Dec 22, 2014
#10	-13.24% May 28, 2021 - Jun 24, 2021	-10.33% Feb 4, 2014 - Feb 12, 2014
#11	-11.94% Apr 27, 2021 - May 14, 2021	-10.22% Oct 20, 2014 - Nov 26, 2014
#12	-11.42% Jun 18, 2020 - Jul 13, 2020	-9.10% May 17, 2018 - Jun 6, 2018
#13	-11.26% Aug 31, 2020 - Sep 14, 2020	-8.05% Feb 12, 2014 - Mar 14, 2014
#14	-8.78% Sep 23, 2020 - Sep 30, 2020	-7.89% Jun 11, 2018 - Jul 2, 2018
#15	-7.19% Sep 14, 2020 - Sep 23, 2020	-6.48% May 8, 2018 - May 17, 2018